Dr Datsons Labs Ltd (DRDA)

Dr.Datsons Labs Limited, an integrated pharmaceutical company, engages in the research, development, manufacturing, marketing, and distribution of active pharmaceutical ingredients (APIs)\bulk drugs, and branded and generic finished dosage forms for various therapeutic segments in India. The company provides anti-malarial, expectorant, emetic, CNS, anti retro-viral, ace inhibitor, erectile dysfunction, animal health, anti-cancer, and diabetic APIs, as well as pain management products. It also offers formulations, such as anti-malarial finished dosages, animal health products, anti TB drug therapy products, expectorants/cold preparations/mucolytes, lozenges, multi vitamin syrups, analgesics, anti-obesity products, erectile dysfunction and hormone replacement therapy products, and topicals. In addition, the company is involved in the provision of contract research and manufacturing services for various Indian pharmaceutical brands in the areas of APIs, branded and regulated generics, and novel drug delivery systems. Dr.Datsons Labs Limited provides its products in the form of lozenges, liquids, topicals, syrups, ointments, and gels. The company also exports its products to 60 countries. The company was formerly known as Aanjaneya Lifecare Limited and changed its name to Dr.Datsons Labs Limited in August 2013. Dr.Datsons Labs Limited was incorporated in 2006 and is based in Mumbai, India.